India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
These symptoms are seen in mental disorders, how to avoid them? Mental disorders negatively affect a person's thinking, behavior, and mood and can lead to diseases such as depression and anxiety. Symptoms of mental disorders are divided into early, moderate, and severe stages, and each stage has different symptoms. Symptoms of mental disorders worsen over time. The rate of psychosis varies from person to person. Genetic factors, age, health conditions, and underlying causes of psychosis can be responsible for the progression of the disease. There are different stages of dementia, which affect health in different ways. Scientists have determined different systems of stages for different types of psychosis related to Alzheimer's disease, but the staging system is not completely accurate and the stages can often overlap with each other. Symptoms may or may not appear at any stage. What is a mental disorder? Mental disorder refers to a condition that negatively affects a person...